awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42417359-1A10BE82-CA1D-4626-92E4-4C5000BBEE52
Q42417359-1A10BE82-CA1D-4626-92E4-4C5000BBEE52
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42417359-1A10BE82-CA1D-4626-92E4-4C5000BBEE52
The changing landscape of treatment options for metastatic castrate-resistant prostate cancer: challenges and solutions for physicians and patients.
P2860
Q42417359-1A10BE82-CA1D-4626-92E4-4C5000BBEE52
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42417359-1A10BE82-CA1D-4626-92E4-4C5000BBEE52
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
013498473cb054669e6065d6fa5c728a6d1fceaa
P2860
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.